Latest Investments News

Lithium Plus Minerals reports promising pegmatite intersections at its Liana Prospect and maintains a solid cash position of A$4.08 million, setting the stage for expanded exploration in 2025.

Jindalee Lithium Limited reported a $935,000 net cash outflow for the December 2024 quarter, maintaining a cautious but confident stance on securing future funding to support ongoing exploration activities.

Jindalee Lithium’s latest quarterly report confirms a 63-year life for its McDermitt Lithium Project, underpinned by robust financial metrics and a maiden ore reserve that taps just a fraction of its vast resource.

Duxton Farms Limited reported a robust Q2 FY2025, driven by favourable weather conditions and strategic investments, including a share buyback and increased stakes in agricultural ventures. The company recorded a $2.24 million operating cash flow surplus amid mixed crop yields and ongoing diversification.

Minbos Resources has officially commenced construction on its Cabinda Phosphate Fertilizer Project, supported by a robust US$36 million financing package from strategic partners including Angola’s Sovereign Wealth Fund and Banco BAI.

MPower Group has finalized the conversion of a $10 million project funding facility for its Narromine Renewable Energy Project into equity, with AMPYR Distributed Energy acquiring full ownership. The move strengthens MPower's balance sheet and supports its strategic push into hybrid renewable assets.

Rare Foods Australia reports an 18% biomass increase and $440k in cost savings, while launching its Subsea Estate brand and securing a $2.1M R&D refund to support growth.

RooLife Group (ASX: RLG) reported a striking 144% increase in sales revenue for Q2 FY2025, driven by the launch of new online stores across China, Hong Kong, Australia, and India. The company is investing heavily in product development and marketing to capitalize on booming health and wellness markets.

Prescient Therapeutics has secured FDA clearance for its PTX-100 Phase 2 trial targeting relapsed/refractory cutaneous T-cell lymphoma, while also appointing James McDonnell as its new CEO. The company reports steady progress in its cell therapy platforms and maintains a solid cash position bolstered by a recent R&D tax rebate.

Ausmon Resources Limited reports steady progress in rare earth and base metals exploration across Australia, with key drilling programs planned for 2025 despite a tight cash position.

Epsilon Healthcare Limited reported a modest cash increase in its December quarter but remains under administration with no unused financing facilities, raising questions about its operational future.

Tombador Iron Limited reported a modest net cash outflow of $317,000 for the December 2024 quarter, yet holds robust cash reserves of $10.825 million, underpinning over 34 quarters of operational funding.